Clinical Trial Update: Phase III Study of Socazolimab as First-Line Treatment in Persistent, Recurrent, or Metastatic Cervical Cancer [Phase 3]

View source ↗

Summary

This document reports an ongoing Phase III trial evaluating Socazolimab as first-line therapy for persistent, recurrent, or metastatic cervical cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cervical Cancer

Drugs mentioned

• Socazolimab

Snippet

Sponsor: Lee's Pharmaceutical Limited | Conditions: Cervical Cancer | Phase 3 | Status: RECRUITING